X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE PANACEA BIOTECH SUVEN LIFE/
PANACEA BIOTECH
 
P/E (TTM) x 14.0 22.7 61.9% View Chart
P/BV x 3.3 3.1 109.2% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 SUVEN LIFE   PANACEA BIOTECH
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
PANACEA BIOTECH
Mar-14
SUVEN LIFE/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs229149 153.7%   
Low Rs15182 183.6%   
Sales per share (Unadj.) Rs42.784.1 50.8%  
Earnings per share (Unadj.) Rs6.9-18.3 -37.4%  
Cash flow per share (Unadj.) Rs8.5-6.7 -127.4%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs52.483.7 62.6%  
Shares outstanding (eoy) m127.2861.25 207.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.41.4 323.8%   
Avg P/E ratio x27.7-6.3 -439.2%  
P/CF ratio (eoy) x22.2-17.2 -129.0%  
Price / Book Value ratio x3.61.4 262.5%  
Dividend payout %14.60-   
Avg Mkt Cap Rs m24,1587,074 341.5%   
No. of employees `0001.02.8 36.9%   
Total wages/salary Rs m5221,449 36.0%   
Avg. sales/employee Rs Th5,349.71,874.1 285.5%   
Avg. wages/employee Rs Th513.5527.0 97.4%   
Avg. net profit/employee Rs Th858.1-407.7 -210.5%   
INCOME DATA
Net Sales Rs m5,4355,154 105.5%  
Other income Rs m211100 211.4%   
Total revenues Rs m5,6465,254 107.5%   
Gross profit Rs m1,291-766 -168.4%  
Depreciation Rs m214711 30.1%   
Interest Rs m571,503 3.8%   
Profit before tax Rs m1,231-2,881 -42.7%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m35917 2,135.9%   
Profit after tax Rs m872-1,121 -77.8%  
Gross profit margin %23.7-14.9 -159.7%  
Effective tax rate %29.2-0.6 -4,999.1%   
Net profit margin %16.0-21.8 -73.7%  
BALANCE SHEET DATA
Current assets Rs m4,9173,810 129.1%   
Current liabilities Rs m1,1868,365 14.2%   
Net working cap to sales %68.6-88.4 -77.7%  
Current ratio x4.10.5 910.2%  
Inventory Days Days62156 39.9%  
Debtors Days Days3167 45.8%  
Net fixed assets Rs m3,15414,480 21.8%   
Share capital Rs m12761 207.7%   
"Free" reserves Rs m6,543903 724.5%   
Net worth Rs m6,6705,127 130.1%   
Long term debt Rs m2595,832 4.4%   
Total assets Rs m8,15719,433 42.0%  
Interest coverage x22.7-0.9 -2,473.2%   
Debt to equity ratio x01.1 3.4%  
Sales to assets ratio x0.70.3 251.3%   
Return on assets %11.42.0 579.6%  
Return on equity %13.1-21.9 -59.8%  
Return on capital %18.63.6 511.0%  
Exports to sales %024.5 0.0%   
Imports to sales %010.2 0.0%   
Exports (fob) Rs mNA1,264 0.0%   
Imports (cif) Rs mNA525 0.0%   
Fx inflow Rs m4,9961,539 324.6%   
Fx outflow Rs m959942 101.8%   
Net fx Rs m4,037597 676.0%   
CASH FLOW
From Operations Rs m1,088599 181.6%  
From Investments Rs m-3,107-438 709.5%  
From Financial Activity Rs m-300-303 99.2%  
Net Cashflow Rs m-2,319-141 1,640.9%  

Share Holding

Indian Promoters % 63.4 74.5 85.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 0.0 1.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 23.6 154.7%  
Shareholders   37,287 10,259 363.5%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   J.B.CHEMICALS  ALEMBIC LTD  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare SUVEN LIFE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weakening Rupee; Key Earnings Report; IDBI Bank, ONGC among Top Stocks in Action Today(Pre-Open)

Indian share markets rose on Friday after rupee recovered from its a 16-month low against the dollar. The S&P BSE Sensex ended at 34,925, up 262 points.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


May 25, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS